Breakthrough Coronavirus Treatment Cures Moderate/Serious COVID-19 Patients within Days

In what is being hailed as a “huge breakthrough,” all the 30 COVID-19 patients with moderate or worse symptoms who had been administered the EXO-CD24 substance recovered from the disease. The substance uses exosomes, or tiny carrier sacs that shuttle materials between cells, to deliver a protein called CD24 to the lungs in order to fight the cytokine storm and calm down the immune system. The scientists will now begin Phase 2 trial of the medicine which could be a potential game-changer in fighting serious COVID-19 illness.

“The preparation is inhaled once a day for a few minutes, for five days,” Prof. Nadir Arber who discovered the substance told The Times of Israel. “The preparation is directed straight to the heart of the storm - the lungs - so unlike other formulas… which selectively restrain a certain cytokine, or operate widely but cause many serious side effects, EXO-CD24 is administered locally, works broadly and without side effects.”

Related Links:
Ichilov Medical Center